This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Novartis Ag, Surface Oncology, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,978 
1 out of 13 
Years Active: 2022
Title: Rachel W O'Connor: Innovator in Antibody Molecules
Introduction
Rachel W O'Connor is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. Her work focuses on innovative solutions for cancer treatment, prevention, and diagnosis.
Latest Patents
Rachel holds a patent for "Antibody molecules to CD73 and uses thereof." This patent discloses antibody molecules that bind to CD73, which can be utilized in various therapeutic applications related to cancer. She has 1 patent to her name, showcasing her expertise and dedication to advancing medical science.
Career Highlights
Throughout her career, Rachel has worked with notable companies such as Novartis AG and Surface Oncology, Inc. These experiences have allowed her to collaborate with leading professionals in the industry and contribute to groundbreaking research.
Collaborations
Rachel has collaborated with talented individuals, including Bianka Prinz and Jerry M Thomas. These partnerships have enriched her work and fostered innovation in her field.
Conclusion
Rachel W O'Connor is a distinguished inventor whose work in antibody molecules has the potential to transform cancer treatment. Her contributions to biotechnology reflect her commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile